Works in Alimentary Pharmacology & Therapeutics, 2020, Vol 51, Issue 12

Results: 33

Letter: Helicobacter pylori eradication treatment and the risk of oesophageal adenocarcinoma.

Published in:

Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 12, p. 1452, doi. 10.1111/apt.15800

By:

Sun, Yulan

Publication type:

Article

Editorial: low population mortality from COVID‐19 in countries south of latitude 35 degrees North—supports vitamin D as a factor determining severity. Authors' reply.

Published in:

Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 12, p. 1438, doi. 10.1111/apt.15796

By:

Garg, Mayur;
Al‐Ani, Aysha;
Mitchell, Hannah;
Hendy, Philip;
Christensen, Britt

Publication type:

Article

Editorial: hepatitis B DNA thresholds and risk of hepatocellular carcinoma: different number patterns in HBeAg‐positive versus HBeAg‐negative patients. Authors' reply.

Published in:

Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 12, p. 1440, doi. 10.1111/apt.15794

By:

Kim, Gi‐Ae;
Lim, Young‐Suk

Publication type:

Article

Editorial: hepatitis B DNA thresholds and risk of hepatocellular carcinoma: different number patterns in HBeAg‐positive versus HBeAg‐negative patients.

Published in:

Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 12, p. 1439, doi. 10.1111/apt.15783

By:

Dusheiko, Geoffrey

Publication type:

Article

Letter: balancing gut hydrogen as a proxy for bacteriotherapy benefits in irritable bowel syndrome.

Published in:

Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 12, p. 1451, doi. 10.1111/apt.15782

By:

Ostojic, Sergej M.

Publication type:

Article

Editorial: low population mortality from COVID‐19 in countries south of latitude 35 degrees North supports vitamin D as a factor determining severity.

Published in:

Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 12, p. 1434, doi. 10.1111/apt.15777

By:

Rhodes, Jonathan M.;
Subramanian, Sreedhar;
Laird, Eamon;
Kenny, Rose A.

Publication type:

Article

Letter: how can we reduce mortality in elderly patients with acute severe ulcerative colitis? Authors' reply.

Published in:

Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 12, p. 1445, doi. 10.1111/apt.15776

By:

Dong, Catherine;
Metzger, Marie;
Holsbø, Einar E.;
Perduca, Vittorio;
Carbonnel, Franck

Publication type:

Article

Review article: impact of cigarette smoking on intestinal inflammation—direct and indirect mechanisms.

Published in:

Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 12, p. 1268, doi. 10.1111/apt.15774

By:

Papoutsopoulou, Stamatia;
Satsangi, Jack;
Campbell, Barry J.;
Probert, Chris S.

Publication type:

Article

Randomised clinical trial: linaclotide vs placebo—a study of bi‐directional gut and brain axis.

Published in:

Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 12, p. 1332, doi. 10.1111/apt.15772

By:

Rao, Satish S.C.;
Xiang, Xuelian;
Yan, Yun;
Rattanakovit, Kulthep;
Patcharatrakul, Tanisa;
Parr, Rachael;
Ayyala, Deepak;
Sharma, Amol

Publication type:

Article

Systematic review: gastrointestinal infection and incident inflammatory bowel disease.

Published in:

Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 12, p. 1222, doi. 10.1111/apt.15770

By:

Axelrad, Jordan E.;
Cadwell, Ken H.;
Colombel, Jean‐Frederic;
Shah, Shailja C.

Publication type:

Article

Editorial: increasing IBD prevalence and its complications in the context of the COVID‐19 pandemic. Authors' reply.

Published in:

Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 12, p. 1442, doi. 10.1111/apt.15769

By:

King, Dominic Stephen;
Trudgill, Nigel John;
Adderley, Nicola J.

Publication type:

Article

Letter: golimumab efficacy in patients with Crohn's disease and concomitant severe arthritis.

Published in:

Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 12, p. 1449, doi. 10.1111/apt.15768

By:

Miceli, Maria Concetta;
Arcuri, Chiara;
Renna, Sara;
Orlando, Ambrogio;
Provenzano, Giuseppe

Publication type:

Article

Transperineal ultrasound predicts endoscopic and histological healing in ulcerative colitis.

Published in:

Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 12, p. 1373, doi. 10.1111/apt.15767

By:

Sagami, Shintaro;
Kobayashi, Taku;
Aihara, Kanako;
Umeda, Misaki;
Morikubo, Hiromu;
Matsubayashi, Mao;
Kiyohara, Hiroki;
Nakano, Masaru;
Ohbu, Makoto;
Hibi, Toshifumi

Publication type:

Article

Risk factors and treatment outcomes of peristomal pyoderma gangrenosum in patients with inflammatory bowel disease.

Published in:

Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 12, p. 1365, doi. 10.1111/apt.15766

By:

Wang, Jingzhou;
Prenner, Joshua;
Wang, Wenfei;
Sakuraba, Atsushi;
Hyman, Neil;
Dalal, Sushila;
Hurst, Roger;
Cohen, Russell D.;
Umanskiy, Konstantin;
Shogan, Benjamin D.;
Alpert, Lindsay;
Rubin, David T.;
Colwell, Janice;
Pekow, Joel

Publication type:

Article

Systematic review: management of localised low‐grade upper gastrointestinal neuroendocrine tumours.

Published in:

Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 12, p. 1247, doi. 10.1111/apt.15765

By:

Exarchou, Klaire;
Howes, Nathan;
Pritchard, David Mark

Publication type:

Article

Editorial: increasing IBD prevalence and its complications in the context of the COVID‐19 pandemic.

Published in:

Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 12, p. 1441, doi. 10.1111/apt.15759

By:

Benson‐Pope, Samantha Jane;
Gearry, Richard B.

Publication type:

Article

Letter: are microbes other than Helicobacter pylori associated with gastric cancer? Authors' reply.

Published in:

Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 12, p. 1447, doi. 10.1111/apt.15757

By:

Gantuya, Boldbaatar;
El‐Serag, Hashem B.;
Yamaoka, Yoshio

Publication type:

Article

A disease‐specific decline of the relative abundance of Bifidobacterium in patients with autoimmune hepatitis.

Published in:

Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 12, p. 1417, doi. 10.1111/apt.15754

By:

Liwinski, Timur;
Casar, Christian;
Ruehlemann, Malte C.;
Bang, Corinna;
Sebode, Marcial;
Hohenester, Simon;
Denk, Gerald;
Lieb, Wolfgang;
Lohse, Ansgar W.;
Franke, Andre;
Schramm, Christoph

Publication type:

Article

Do the circulating Pre‐S/S quasispecies influence hepatitis B virus surface antigen levels in the HBeAg negative phase of HBV infection?

Published in:

Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 12, p. 1406, doi. 10.1111/apt.15753

By:

Cavallone, Daniela;
Ricco, Gabriele;
Oliveri, Filippo;
Colombatto, Piero;
Moriconi, Francesco;
Coco, Barbara;
Romagnoli, Veronica;
Salvati, Antonio;
Surace, Lidia;
Bonino, Ferruccio;
Brunetto, Maurizia Rossana

Publication type:

Article

Systematic review: medical therapy for fibrostenosing Crohn's disease.

Published in:

Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 12, p. 1233, doi. 10.1111/apt.15750

By:

Lu, Cathy;
Baraty, Brandon;
Lee Robertson, Helen;
Filyk, Alexis;
Shen, Hua;
Fung, Tak;
Novak, Kerri;
Ma, Christopher;
Panaccione, Remo;
Achkar, Jean‐Paul;
El Ouali, Sara;
Bruining, David;
Jairath, Vipul;
Feagan, Brian;
Rieder, Florian

Publication type:

Article

Outcomes after hepatic encephalopathy in population‐based cohorts of patients with cirrhosis.

Published in:

Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 12, p. 1397, doi. 10.1111/apt.15749

By:

Tapper, Elliot B.;
Aberasturi, Devin;
Zhao, Zhe;
Hsu, Chia‐Yang;
Parikh, Neehar D.

Publication type:

Article

Review article: opportunities to improve and expand thiopurine therapy for autoimmune hepatitis.

Published in:

Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 12, p. 1286, doi. 10.1111/apt.15743

By:

Czaja, Albert J.

Publication type:

Article

A virtual clinic increases anti‐TNF dose intensification success via a treat‐to‐target approach compared with standard outpatient care in Crohn's disease.

Published in:

Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 12, p. 1342, doi. 10.1111/apt.15742

By:

Srinivasan, Ashish;
van Langenberg, Daniel R.;
Little, Robert D.;
Sparrow, Miles P.;
De Cruz, Peter;
Ward, Mark G.

Publication type:

Article

Randomised clinical trial: faecal microbiota transplantation versus autologous placebo administered via colonoscopy in irritable bowel syndrome.

Published in:

Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 12, p. 1321, doi. 10.1111/apt.15740

By:

Lahtinen, Perttu;
Jalanka, Jonna;
Hartikainen, Anna;
Mattila, Eero;
Hillilä, Markku;
Punkkinen, Jari;
Koskenpato, Jari;
Anttila, Veli‐Jukka;
Tillonen, Jyrki;
Satokari, Reetta;
Arkkila, Perttu

Publication type:

Article

Review article: the emerging role of genetics in precision medicine for patients with non‐alcoholic steatohepatitis.

Published in:

Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 12, p. 1305, doi. 10.1111/apt.15738

By:

Carlsson, Björn;
Lindén, Daniel;
Brolén, Gabriella;
Liljeblad, Mathias;
Bjursell, Mikael;
Romeo, Stefano;
Loomba, Rohit

Publication type:

Article

Limited added value of laboratory monitoring in thiopurine maintenance monotherapy in inflammatory bowel disease patients.

Published in:

Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 12, p. 1353, doi. 10.1111/apt.15734

By:

Kreijne, Joany E.;
Vries, Annemarie C.;
Veer, Rozanne C.;
Bouma, Gerd;
Dijkstra, Gerard;
Voskuil, Michiel D.;
West, Rachel;
Moorsel, Sofia A. W.;
Jong, Dirk J.;
Boer, Nanne K.;
Woude, C. Janneke

Publication type:

Article

Editorial: hepatitis C and porphyria cutanea tarda in 2020.

Published in:

Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 12, p. 1432, doi. 10.1111/apt.15728

By:

Rudnick, Sean;
Bonkovsky, Herbert L.

Publication type:

Article

Letter: are microbes other than Helicobacter pylori associated with gastric cancer?

Published in:

Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 12, p. 1446, doi. 10.1111/apt.15727

By:

He, Cong;
Peng, Chao;
Xia, Zhongkui;
Lu, Nonghua

Publication type:

Article

Editorial: increasing burden of nonalcoholic fatty liver disease—a call to action. Authors' reply.

Published in:

Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 12, p. 1430, doi. 10.1111/apt.15718

By:

Estes, Chris;
Chan, Henry L. Y.;
Chien, Rong N.;
Chuang, Wan‐Long;
Fung, James;
Goh, George Boon‐Bee;
Hu, Tsung H.;
Huang, Jee‐Fu;
Jang, Byoung K.;
Jun, Dae W.;
Kao, Jia H.;
Lee, Jin‐Woo;
Lin, Han‐Chieh;
Razavi‐Shearer, Kathryn;
Seto, Wai‐Kay;
Wong, Grace L.‐H.;
Wong, Vincent W.‐S.;
Razavi, Homie

Publication type:

Article

Impact of a digital medicine programme on hepatitis C treatment adherence and efficacy in adults at high risk for non‐adherence.

Published in:

Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 12, p. 1384, doi. 10.1111/apt.15707

By:

Sulkowski, Mark;
Luetkemeyer, Annie F.;
Wyles, David L.;
Martorell, Claudia;
Muir, Andrew;
Weisberg, Ilan;
Gordon, Stuart C.;
McLain, Richard;
Huhn, Gregory

Publication type:

Article

Letter: how can we reduce mortality in elderly patients with acute severe ulcerative colitis?

Published in:

Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 12, p. 1444, doi. 10.1111/apt.15702

By:

Li Wai Suen, Christopher F.D.;
Choy, Matthew C.;
De Cruz, Peter

Publication type:

Article

Editorial: increasing burden of nonalcoholic fatty liver disease—a call to action.

Published in:

Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 12, p. 1429, doi. 10.1111/apt.15700

By:

Chuah, Kee‐Huat;
Chan, Wah‐Kheong

Publication type:

Article

Issue Information.

Published in:: Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 12, p. 1219, doi. 10.1111/apt.15348
Publication type:: Article